212 related articles for article (PubMed ID: 28340113)
1. GATA1 Is a Sensitive and Specific Nuclear Marker for Erythroid and Megakaryocytic Lineages.
Lee WY; Weinberg OK; Pinkus GS
Am J Clin Pathol; 2017 Apr; 147(4):420-426. PubMed ID: 28340113
[TBL] [Abstract][Full Text] [Related]
2. Contribution of GATA1 dysfunction to multi-step leukemogenesis.
Shimizu R; Yamamoto M
Cancer Sci; 2012 Dec; 103(12):2039-44. PubMed ID: 22937757
[TBL] [Abstract][Full Text] [Related]
3. Alpha- and beta-synucleins are new diagnostic tools for acute erythroid leukemia and acute megakaryoblastic leukemia.
Maitta RW; Wolgast LR; Wang Q; Zhang H; Bhattacharyya P; Gong JZ; Sunkara J; Albanese JM; Pizzolo JG; Cannizzaro LA; Ramesh KH; Ratech H
Am J Hematol; 2011 Feb; 86(2):230-4. PubMed ID: 21264917
[TBL] [Abstract][Full Text] [Related]
4. GATA-1 is expressed in acute erythroblastic leukaemia.
Ekert H; Sievers EL; Tan A; Martin DI; Smith FO; Barnard D; Bernstein ID
Br J Haematol; 1994 Feb; 86(2):410-2. PubMed ID: 8199039
[TBL] [Abstract][Full Text] [Related]
5. GATA1 insufficiencies in primary myelofibrosis and other hematopoietic disorders: consequences for therapy.
Ling T; Crispino JD; Zingariello M; Martelli F; Migliaccio AR
Expert Rev Hematol; 2018 Mar; 11(3):169-184. PubMed ID: 29400094
[TBL] [Abstract][Full Text] [Related]
6. The Comparative Sensitivity of Immunohistochemical Markers of Megakaryocytic Differentiation in Acute Megakaryoblastic Leukemia.
Klairmont MM; Hoskoppal D; Yadak N; Choi JK
Am J Clin Pathol; 2018 Oct; 150(5):461-467. PubMed ID: 30052718
[TBL] [Abstract][Full Text] [Related]
7. The leukemia associated ETO nuclear repressor gene is regulated by the GATA-1 transcription factor in erythroid/megakaryocytic cells.
Ajore R; Dhanda RS; Gullberg U; Olsson I
BMC Mol Biol; 2010 May; 11():38. PubMed ID: 20487545
[TBL] [Abstract][Full Text] [Related]
8. Nuclear interacting SET domain protein 1 inactivation impairs GATA1-regulated erythroid differentiation and causes erythroleukemia.
Leonards K; Almosailleakh M; Tauchmann S; Bagger FO; Thirant C; Juge S; Bock T; Méreau H; Bezerra MF; Tzankov A; Ivanek R; Losson R; Peters AHFM; Mercher T; Schwaller J
Nat Commun; 2020 Jun; 11(1):2807. PubMed ID: 32533074
[TBL] [Abstract][Full Text] [Related]
9. Loss of Full-Length GATA1 Expression in Megakaryocytes Is a Sensitive and Specific Immunohistochemical Marker for the Diagnosis of Myeloid Proliferative Disorder Related to Down Syndrome.
Lee WY; Weinberg OK; Evans AG; Pinkus GS
Am J Clin Pathol; 2018 Mar; 149(4):300-309. PubMed ID: 29481579
[TBL] [Abstract][Full Text] [Related]
10. Blasts in transient leukaemia in neonates with Down syndrome differentiate into basophil/mast-cell and megakaryocyte lineages in vitro in association with down-regulation of truncated form of GATA1.
Miyauchi J; Ito Y; Tsukamoto K; Takahashi H; Ishikura K; Sugita K; Miyashita T
Br J Haematol; 2010 Mar; 148(6):898-909. PubMed ID: 20064153
[TBL] [Abstract][Full Text] [Related]
11. An intricate regulatory circuit between FLI1 and GATA1/GATA2/LDB1/ERG dictates erythroid vs. megakaryocytic differentiation.
Wang C; Hu M; Yu K; Liu W; Hu A; Kuang Y; Huang L; Gajendran B; Zacksenhaus E; Xiao X; Ben-David Y
Mol Med Rep; 2024 Jun; 29(6):. PubMed ID: 38695236
[TBL] [Abstract][Full Text] [Related]
12. Expression of erythroid-specific genes in megakaryoblastic disorders.
Ito E; Kasai M; Toki T; Arai K; Yokoyama M
Leuk Lymphoma; 1996 Nov; 23(5-6):545-50. PubMed ID: 9031085
[TBL] [Abstract][Full Text] [Related]
13. α-Hemoglobin-stabilizing Protein: An Effective Marker for Erythroid Precursors in Bone Marrow Biopsy Specimens.
Yu H; Pinkus JL; Pinkus GS
Appl Immunohistochem Mol Morphol; 2016 Jan; 24(1):51-6. PubMed ID: 25611244
[TBL] [Abstract][Full Text] [Related]
14. A unique role of GATA1s in Down syndrome acute megakaryocytic leukemia biology and therapy.
Xavier AC; Edwards H; Dombkowski AA; Balci TB; Berman JN; Dellaire G; Xie C; Buck SA; Matherly LH; Ge Y; Taub JW
PLoS One; 2011; 6(11):e27486. PubMed ID: 22110660
[TBL] [Abstract][Full Text] [Related]
15. Early block to erythromegakaryocytic development conferred by loss of transcription factor GATA-1.
Stachura DL; Chou ST; Weiss MJ
Blood; 2006 Jan; 107(1):87-97. PubMed ID: 16144799
[TBL] [Abstract][Full Text] [Related]
16. Regulation of GATA factor expression is distinct between erythroid and mast cell lineages.
Ohmori S; Takai J; Ishijima Y; Suzuki M; Moriguchi T; Philipsen S; Yamamoto M; Ohneda K
Mol Cell Biol; 2012 Dec; 32(23):4742-55. PubMed ID: 22988301
[TBL] [Abstract][Full Text] [Related]
17. The proto-oncogene ERG in megakaryoblastic leukemias.
Rainis L; Toki T; Pimanda JE; Rosenthal E; Machol K; Strehl S; Göttgens B; Ito E; Izraeli S
Cancer Res; 2005 Sep; 65(17):7596-602. PubMed ID: 16140924
[TBL] [Abstract][Full Text] [Related]
18. Mutations in GATA1 in both transient myeloproliferative disorder and acute megakaryoblastic leukemia of Down syndrome.
Greene ME; Mundschau G; Wechsler J; McDevitt M; Gamis A; Karp J; Gurbuxani S; Arceci R; Crispino JD
Blood Cells Mol Dis; 2003; 31(3):351-6. PubMed ID: 14636651
[TBL] [Abstract][Full Text] [Related]
19. Pluripotent stem cell model of early hematopoiesis in Down syndrome reveals quantitative effects of short-form GATA1 protein on lineage specification.
Matsuo S; Nishinaka-Arai Y; Kazuki Y; Oshimura M; Nakahata T; Niwa A; Saito MK
PLoS One; 2021; 16(3):e0247595. PubMed ID: 33780474
[TBL] [Abstract][Full Text] [Related]
20. GLUT1 Immunohistochemistry Is a Highly Sensitive and Relatively Specific Marker for Erythroid Lineage in Benign and Malignant Hematopoietic Tissues.
Kaumeyer BA; Fidai SS; Thakral B; Wang SA; Arber DA; Cheng JX; Gurbuxani S; Venkataraman G
Am J Clin Pathol; 2022 Aug; 158(2):228-234. PubMed ID: 35311938
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
